The PhilaDelic Fall Forum laid out a roadmap for wider use of ibogaine and mushrooms to treat addiction and depression as stigma fades. Leading chemists, psychiatrists, treatment professionals, academics and activists gathered to expand the medical use of psychedelic drugs. After spending the day with therapists, scientists and patients at the PhilaDelic Fall Forum, it… Keep Reading
Medical research into using the psychedelic MDMA to treat post-traumatic stress disorder is being called into question following allegations that a clinical trial investigating the treatment was potentially tainted by misconduct. The U.S. Food and Drug Administration is currently conducting a review of the psychedelic commonly called ecstasy for patients with PTSD. The treatment is… Keep Reading
As it turns out, researching the efficacy of MDMA to treat PTSD may be pretty complicated. The initial efforts to secure governmental sanction for a psychedelic substance for mental health care, in this case, MDMA, are facing some serious scrutiny over the clinical trial process, the Washington Post reports. MDMA has long been lauded as… Keep Reading
Departing Berkeley, California on a foggy Wednesday morning, I was in for a treat. I knew I was headed to my favorite place and to what is, in my experience, the best cannabis farm in the world. On the drive north, everything got more beautiful, sunnier, golden, and green. I drove all the way to… Keep Reading
Alvi Ghaznavi’s cannabis journey began in his early 20s as a patient looking to treat his Irritable Bowel Syndrome (IBS) symptoms that had once made work impossible and life unbearable. He’d pivot from the underground to the New Jersey medical market when the state legalized its use. Living what he called “a very wholesome, blessed… Keep Reading
